General Pharma

General Pharmaceuticals Limited, commonly referred to as General Pharma or GPL, is a pharmaceutical company based in Bangladesh. The company was incorporated as a private limited company on 5 April 1984, with A.K.M. Zahirul Alam serving as managing director and Gazi Nurun Nabi as a director at the time of incorporation. Commercial manufacturing began in 1987 with an initial portfolio of seven products. The company manufactures a broad range of pharmaceutical dosage forms at its production facility in Gazipur, approximately 72 kilometres from Dhaka. Its capabilities include film-coated, enteric-coated, dispersible, immediate-release, modified-release, sustained-release and chewable tablets; immediate-release, modified-release and enteric-coated capsules; liquid-filled hard-gelatin capsules; oral liquids and semisolids; oral rehydration salts; antiseptic products; creams; ointments; lotions; gels; and powders for suspension. This breadth gives GPL a manufacturing profile spanning solid oral medicines, liquids, topical preparations and selected healthcare products. General Pharma expanded its Gazipur manufacturing site in 2011. The facility is reported to occupy approximately 29,792 square metres, with a building footprint of about 14,444 square metres. The site supports the company's domestic supply activities and its export business. General Pharma sells products in Bangladesh and has registered products for distribution in markets across Asia, Africa, and Central and South America. Its reported Asian export destinations include Afghanistan, Bhutan, Cambodia, Sri Lanka, Myanmar, Hong Kong, Macau, Vietnam, the Maldives and the Philippines. African destinations include Kenya, Somalia, Mauritius, Nigeria, Burkina Faso and Libya, while Belize and Guatemala are identified in Central and South America. The company's operating model combines manufacturing with a nationwide distribution and commercial organization in Bangladesh. Reference material describes a workforce of nearly 3,000 people, including approximately 2,000 sales and marketing employees, together with a national distribution network involving about 600 distribution workers. General Pharma has also expressed an ambition to expand into additional markets in Southeast Asia, the Middle East and Africa. Publicly available reference material provides limited information about the company's product trademarks, financial performance, ownership, current leadership, regulatory record and corporate website. Accordingly, this entry focuses on the documented corporate history, manufacturing capabilities and geographic footprint rather than attributing unverified brands, financial figures or current executives to the company.

General Pharmaceuticals Limited was incorporated as a private limited company on 5 April 1984 in Bangladesh. The founding corporate leadership identified in reference material consisted of A.K.M. Zahirul Alam as managing director and Gazi Nurun Nabi as a director. The business entered pharmaceutical manufacturing in 1987, initially producing seven products. Over time, General Pharma developed a substantially broader manufacturing platform. Its principal facility was established in Gazipur, roughly 72 kilometres from Dhaka, and supports multiple pharmaceutical dosage forms. These include several tablet technologies—film-coated, enteric-coated, dispersible, immediate-release, modified-release, sustained-release and chewable—as well as immediate-release, modified-release and enteric-coated capsules. The facility also produces liquid-filled hard-gelatin capsules, oral rehydration salts, syrups, suspensions, oral gels, antiseptic mouthwash, antiseptic solutions, creams, ointments, lotions and powders for suspension. The company extended its Gazipur manufacturing facility in 2011. The expanded site was described as having a total area of 29,792 square metres and a building footprint of 14,444 square metres. The expansion represents a documented stage in the development of the company's production infrastructure, although the available reference does not specify the individual production lines, investment value or capacity added. General Pharma's commercial activity is centered on Bangladesh, where it maintains a national distribution network. Reference material describes nearly 3,000 employees, including around 2,000 people in sales and marketing, and approximately 600 workers connected with national distribution. These figures indicate a business model combining domestic pharmaceutical manufacturing with a sizable commercial and logistics organization. The company also developed an export presence. Its products were registered in a range of developing and developed markets across Asia, Africa, and Central and South America. The documented markets include Afghanistan, Bhutan, Cambodia, Sri Lanka, Myanmar, Hong Kong, Macau, Vietnam, the Maldives, the Philippines, Kenya, Somalia, Mauritius, Nigeria, Burkina Faso, Libya, Belize and Guatemala. General Pharma has reportedly sought further expansion in Southeast Asia, the Middle East and Africa. The available source material does not establish the company's current ownership structure, listed status, current chief executive, principal consumer-facing product brands, revenue, or detailed regulatory history. Those areas therefore remain unspecified in this dossier.

1. 2011Gazipur facility expanded

   General Pharma extended its manufacturing facility in Gazipur. The site was described as covering 29,792 square metres, with a building footprint of 14,444 square metres.

   Source
2. 1987Pharmaceutical manufacturing begins

   The company began manufacturing pharmaceutical products, initially with seven products.

   Source
3. 1984Company incorporated

   General Pharmaceuticals Limited was incorporated as a private limited company on 5 April 1984.

   Source

A Bangladesh-based pharmaceutical manufacturer with a broad dosage-form portfolio, nationwide domestic distribution and an established export orientation.

• TabletsSolid oral dosage forms

  General Pharma's tablet manufacturing capabilities include film-coated, enteric-coated, dispersible, immediate-release, modified-release, sustained-release and chewable formats. The available reference identifies these as manufacturing categories rather than individual branded products or therapeutic indications.

• CapsulesSolid oral dosage forms

  The company produces immediate-release, modified-release and enteric-coated capsules, as well as liquid-filled hard-gelatin capsules. Specific active ingredients, brands and launch dates are not identified in the available reference material.

• Oral liquids and suspensionsLiquid medicines

  The Gazipur facility produces syrups, suspensions and powders for suspension. These formats form part of the company's broader oral-medicine manufacturing platform, but the source does not specify the relevant product names or therapeutic areas.

• Topical and antiseptic productsTopical and antiseptic preparations

  General Pharma's documented topical and antiseptic capabilities include lotions, water-based and oil-based creams, ointments, oral gels, antiseptic mouthwash and antiseptic solutions. Individual trademarks and formulations are not listed in the supplied reference.

• Oral rehydration saltsSupportive healthcare products

  Oral rehydration salts are among the dosage-form categories manufactured by the company. No specific brand name, formulation details or launch date is provided.

1. General Pharma